These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36732734)

  • 41. Home spirometry in patients with idiopathic pulmonary fibrosis: data from the INMARK trial.
    Noth I; Cottin V; Chaudhuri N; Corte TJ; Johannson KA; Wijsenbeek M; Jouneau S; Michael A; Quaresma M; Rohr KB; Russell AM; Stowasser S; Maher TM;
    Eur Respir J; 2021 Jul; 58(1):. PubMed ID: 33419890
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Design of a Study Assessing Disease Behaviour During the Peri-Diagnostic Period in Patients with Interstitial Lung Disease: The STARLINER Study.
    Wijsenbeek M; Bendstrup E; Valenzuela C; Henry MT; Moor C; Bengus M; Perjesi A; Gilberg F; Kirchgaessler KU; Vancheri C
    Adv Ther; 2019 Jan; 36(1):232-243. PubMed ID: 30506309
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of dexamethasone in patients with ARDS and COVID-19 - prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial.
    Maláska J; Stašek J; Duška F; Balík M; Máca J; Hruda J; Vymazal T; Klementová O; Zatloukal J; Gabrhelík T; Novotný P; Demlová R; Kubátová J; Vinklerová J; Svobodník A; Kratochvíl M; Klučka J; Gál R; Singer M;
    Trials; 2021 Mar; 22(1):172. PubMed ID: 33648568
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Estimates of epidemiology, mortality and disease burden associated with progressive fibrosing interstitial lung disease in France (the PROGRESS study).
    Nasser M; Larrieu S; Boussel L; Si-Mohamed S; Bazin F; Marque S; Massol J; Thivolet-Bejui F; Chalabreysse L; Maucort-Boulch D; Hachulla E; Jouneau S; Le Lay K; Cottin V
    Respir Res; 2021 May; 22(1):162. PubMed ID: 34030695
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Safety and tolerability of pirfenidone in asbestosis: a prospective multicenter study.
    Miedema JR; Moor CC; Veltkamp M; Baart S; Lie NSL; Grutters JC; Wijsenbeek MS; Mostard RLM
    Respir Res; 2022 May; 23(1):139. PubMed ID: 35643466
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
    Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
    Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Utilizing Real-time Technology to Assess the Impact of Home Environmental Exposures on Asthma Symptoms: Protocol for an Observational Pilot Study.
    Nyenhuis S; Cramer E; Grande M; Huntington-Moskos L; Krueger K; Bimbi O; Polivka B; Eldeirawi K
    JMIR Res Protoc; 2022 Aug; 11(8):e39887. PubMed ID: 35916686
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Randomized clinical trial to compare the efficacy of ivermectin versus placebo to negativize nasopharyngeal PCR in patients with early COVID-19 in Peru (SAINT-Peru): a structured summary of a study protocol for randomized controlled trial.
    Garcia PJ; Mundaca H; Ugarte-Gil C; Leon P; Malaga G; Chaccour C; Carcamo CP
    Trials; 2021 Apr; 22(1):262. PubMed ID: 33836826
    [TBL] [Abstract][Full Text] [Related]  

  • 50. REALizing and improving management of stable COPD in China: a multi-center, prospective, observational study to realize the current situation of COPD patients in China (REAL) - rationale, study design, and protocol.
    Yang T; Cai B; Cao B; Kang J; Wen F; Yao W; Zheng J; Ling X; Shang H; Wang C
    BMC Pulm Med; 2020 Jan; 20(1):11. PubMed ID: 31931767
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Visual analogue scales for interstitial lung disease: a prospective validation study.
    Yates H; Adamali HI; Maskell N; Barratt S; Sharp C
    QJM; 2018 Aug; 111(8):531-539. PubMed ID: 29788503
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Once daily long-acting beta2-agonists and long-acting muscarinic antagonists in a combined inhaler versus placebo for chronic obstructive pulmonary disease.
    Maqsood U; Ho TN; Palmer K; Eccles FJ; Munavvar M; Wang R; Crossingham I; Evans DJ
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD012930. PubMed ID: 30839102
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A prospective randomised controlled mixed-methods pilot study of home monitoring in adults with cystic fibrosis.
    Nash EF; Choyce J; Carrolan V; Justice E; Shaw KL; Sitch A; Mistry H; Whitehouse JL
    Ther Adv Respir Dis; 2022; 16():17534666211070133. PubMed ID: 35274585
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The feasibility and acceptability of a home-based, virtual exercise intervention for older patients with hepatocellular carcinoma: protocol for a non-randomised feasibility study (TELEX-Liver Cancer).
    Orange ST; Hallsworth K; Brown MC; Reeves HL
    Pilot Feasibility Stud; 2022 May; 8(1):113. PubMed ID: 35624520
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 56. PROTECT Trial: A cluster-randomized study with hydroxychloroquine versus observational support for prevention or early-phase treatment of Coronavirus disease (COVID-19): A structured summary of a study protocol for a randomized controlled trial.
    Nanni O; Viale P; Vertogen B; Lilli C; Zingaretti C; Donati C; Masini C; Monti M; Serra P; Vespignani R; Grossi V; Biggeri A; Scarpi E; Galardi F; Bertoni L; Colamartini A; Falcini F; Altini M; Massa I; Gaggeri R; Martinelli G
    Trials; 2020 Jul; 21(1):689. PubMed ID: 32736597
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High-dose vitamin D versus placebo to prevent complications in COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial (CARED-TRIAL).
    Mariani J; Tajer C; Antonietti L; Inserra F; Ferder L; Manucha W
    Trials; 2021 Feb; 22(1):111. PubMed ID: 33522946
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comprehensive investigation of novel serum markers of pulmonary fibrosis associated with systemic sclerosis and dermato/polymyositis.
    Kumánovics G; Minier T; Radics J; Pálinkás L; Berki T; Czirják L
    Clin Exp Rheumatol; 2008; 26(3):414-20. PubMed ID: 18578962
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The minimal important difference of the King's Brief Interstitial Lung Disease Questionnaire (K-BILD) and forced vital capacity in interstitial lung disease.
    Patel AS; Siegert RJ; Keir GJ; Bajwah S; Barker RD; Maher TM; Renzoni EA; Wells AU; Higginson IJ; Birring SS
    Respir Med; 2013 Sep; 107(9):1438-43. PubMed ID: 23867809
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.